Register now!Newsletter subscription

  • CATALOG PDF Download
  • BROCHURES PDF Download

The unique tool which inhibits the innate immunity of insects!

Drosophila Diptericin Inhibitor


Innate immunity comprises evolutionarily conserved self-defense mechanisms against microbial infections. In mammals, innate immunity interacts with adaptive immunity and has a key role in the regulated immune response. Therefore, innate immunity is a pharmaceutical target for the development of immune regulators. Using Drosophila ex vivo culture systems (Yajima et al. Biochem. J. 371, 205-210, 2003), a cyclopentanediol analogue is isolated from Aspergillus sp. as an immunosuppressive substance (Sekiya et al. Biochem. Pharm. 75, 2165-2174, 2008). This compound selectively suppresses activation of the imd pathway in Drosophila in vivo and the target molecules of the compound lie between the Imd adaptor protein and dTAK1 kinase in the imd pathway. In human cells, the compound suppresses TNF-a, but not IL-1β, stimulation-induced activation of NF-kB, suggesting that its target molecules are upstream of TAK1 in mammalian innate immunity. The compouns, TPS-17 and TPS-19, are developed from the cyclopentanediol analogue (Kikuchi et al. Eur.J.Med.Chem 46. 1263-1273, 2011).

TPS-17 ((E)-3-(c-3,c-4-dihydroxycyclopent-r-1-yl)propenamide)

C8H13NO3, IC50: 3 ug/ml

TPS-19 ((E)-N-methyl-3-(c-3,c-4-dihydroxycyclopent-r-1-yl)propenamide)

C9H15NO3, IC50: 1 ug/ml

Product List

Product Name Cat# Quantity Price

Drosophila Diptericin Inhibitor TPS-17

CSR-TPS-17 500UG

¥ 30,000
$ 400
€ 300

Drosophila Diptericin Inhibitor TPS-19

CSR-TPS-19 500UG

¥ 30,000
$ 400
€ 300


1) M. Yajima, M. Takada, N. Takahashi, H. Kikuchi, S. Natori, Y. Oshima, and S. Kurata: "A Newly Established in Vitro Culture Using Transgenic Drosophila Reveals Functional Coupling between the Phospholipase A2-generated Fatty Acid Cascade and Lipopolysaccharide-dependent Activation of the immune deficiency (imd) Pathway in Insect Immunity" Biochem. J., 371, 205-210 (2003).
2) M. Sekiya, K. Ueda, K. Okazaki, H. Kikuchi, S. Kurata, and Y. Oshima."A Cyclopentanediol Analogue Selectively Suppresses the Conserved Innate Immunity Pathways, Drosophila IMD and TNF-a Pathways" Biochem. Pharmacol., 75, 2165-2174 (2008).
3) H. Kikuchi, K. Okazaki, M. Sekiya, Y. Uryu, Y. Katou, K. Ueda, S. Kurata, Y. Oshima: "Synthesis and innate immunosuppressive effect of 1,2-cyclopentanediol derivatives" Eur.J.Med.Chem 46. 1263-1273 (2011).

To be used for research only. DO NOT use for human gene therapy or clinical diagnosis.